Véronique Blanchard-Brégeon

Statistics

Publications

Citations

103

H-Index

Active since

2017

Affiliations

Sanofi (France)(Current)

Véronique Blanchard-Brégeon is an author at Sanofi (France) specializing in therapeutic antibody design, neurodegenerative diseases, and molecular basis of neurodegeneration.

Publications per year

2017–2018

Publications

NF-L in cerebrospinal fluid and serum is a biomarker of neuronal damage in an inducible mouse model of neurodegeneration

Anthony Brureau, Véronique Blanchard-Brégeon, Catherine Pech et al. · Neurobiology of Disease · 2017 · 60 citations · Full text

Life Sciences, Neurology, Neuroscience +17

SAR228810: an antibody for protofibrillar amyloid β peptide designed to reduce the risk of amyloid-related imaging abnormalities (ARIA)

Laurent Pradier, Véronique Blanchard-Brégeon, Andrees Bohme et al. · Alzheimer s Research & Therapy · 2018 · 43 citations · Full text

Pharmacy, Immunology, Pharmacology +17

1–2 of 2